What's Happening?
Yale New Haven Health has announced the appointment of Thomas Jackiewicz as its new chief executive officer, effective February 1, 2027. Jackiewicz will succeed Pamela Sutton-Wallace, who has been serving as acting CEO since June. A nationally recognized
healthcare executive, Jackiewicz brings extensive experience from leading three major academic health systems. Since 2020, he has served as president of the University of Chicago Health System. Prior to that, he was the Chief Executive Officer of the University of Southern California’s health system, Keck Medicine, and also held the CEO position at the University of California San Diego Health System from 2009 to 2011. His career also includes two years as chief financial officer of Health Sciences. Jackiewicz was recognized in 2025 as one of Modern Healthcare’s '100 Most Influential People in Healthcare.'
Why It's Important?
The appointment of Thomas Jackiewicz is a significant development for Yale New Haven Health, one of the nation's leading healthcare systems. His proven track record in driving growth, financial performance, clinical expansion, and strengthening partnerships between health systems and academic institutions suggests a strategic direction focused on continued advancement and integration. Given his experience with major academic health systems, Jackiewicz is expected to further enhance Yale New Haven Health's affiliation with Yale University and Yale Medicine, potentially leading to advancements in medical research, education, and patient care. His leadership will be crucial in navigating the complex and evolving healthcare landscape, including challenges related to financial sustainability, technological innovation, and patient access. This leadership change could influence healthcare delivery and policy within Connecticut and the broader New England region, impacting thousands of patients and healthcare professionals.
What's Next?
Thomas Jackiewicz will officially assume his role as Chief Executive Officer on February 1, 2027. His immediate priorities will likely include a comprehensive assessment of Yale New Haven Health's current operations, strategic initiatives, and financial health. Given his background, he is expected to focus on leveraging the system's academic affiliations to drive innovation in clinical care and research. He will also need to address ongoing challenges in the healthcare sector, such as workforce shortages, rising costs, and the integration of new technologies. Stakeholders, including employees, patients, and community partners, will be observing his leadership for continuity and potential new directions. His appointment could also lead to shifts in the system's long-term strategic planning, potentially impacting its various hospitals and specialty networks, including Westerly Hospital, which has seen significant investment since affiliating with Yale New Haven Health.
Beyond the Headlines
Jackiewicz's appointment reflects a broader trend in healthcare leadership towards executives with deep experience in managing complex academic medical centers. These leaders are often tasked with balancing the tripartite mission of patient care, research, and education, while also ensuring financial viability in a highly competitive market. His recognition as one of the '100 Most Influential People in Healthcare' indicates his standing within the industry and suggests a leadership style that has achieved notable success in previous roles. The transition from an acting CEO to a permanent one also signals a period of stability and renewed strategic focus for Yale New Haven Health. This leadership change could influence the system's approach to regional healthcare integration, its investment in new medical technologies, and its engagement with community health initiatives, ultimately shaping the future of healthcare delivery in Connecticut.













